FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157486406> ?p ?o ?g. }

• W2157486406 endingPage "567" @default.
• W2157486406 startingPage "561" @default.
• W2157486406 abstract "The purpose of this randomized study was to examine if goserelin concomitant to CMF-chemotherapy as adjuvant treatment for premenopausal breast cancer, protects the ovaries from premature failure. A total of 285 premenopausal breast cancer patients, in a randomized adjuvant trial (Zoladex in premenopausal patients (ZIPP)), were assigned to a study on ovarian function. Node positive patients were assigned to CMF-(cyclophosphamide, methotrexate and 5-fluorouracil) chemotherapy in addition to endocrine therapy. All patients were randomly assigned to receive 2 years of goserelin, goserelin plus tamoxifen, tamoxifen alone or no endocrine treatment. We studied, if menses were affected in the treatment groups, up to 36 months after randomization. One year after completed CMF- and endocrine therapy, 36% of the women in the goserelin group reported menses, compared to 7% in the goserelin plus tamoxifen group, 13% in the tamoxifen group and 10% of the controls. Among women treated with goserelin, there was a statistically significant increase in the proportion of menstruating women, 1 year after completed treatment compared to at 24 months of treatment (P = 0.006), in contrast to all other treatment groups, who were unchanged or more often amenorrheic. In our study, there is some evidence of protective effect of goserelin on ovarian function in CMF treated women. This effect was not observed in the combined tamoxifen and goserelin treatment." @default.
• W2157486406 created "2016-06-24" @default.
• W2157486406 creator A5047819372 @default.
• W2157486406 creator A5067182789 @default.
• W2157486406 creator A5075557023 @default.
• W2157486406 creator A5088845988 @default.
• W2157486406 date "2009-01-20" @default.
• W2157486406 modified "2023-10-03" @default.
• W2157486406 title "Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial" @default.
• W2157486406 cites W1491616134 @default.
• W2157486406 cites W1761951195 @default.
• W2157486406 cites W1947641090 @default.
• W2157486406 cites W1955291661 @default.
• W2157486406 cites W1961026612 @default.
• W2157486406 cites W1963592300 @default.
• W2157486406 cites W1963740910 @default.
• W2157486406 cites W1971126598 @default.
• W2157486406 cites W1976281058 @default.
• W2157486406 cites W2012182920 @default.
• W2157486406 cites W2017861483 @default.
• W2157486406 cites W2041294899 @default.
• W2157486406 cites W2049473156 @default.
• W2157486406 cites W2053403703 @default.
• W2157486406 cites W2075213874 @default.
• W2157486406 cites W2081333800 @default.
• W2157486406 cites W2088927676 @default.
• W2157486406 cites W2088996917 @default.
• W2157486406 cites W2101760255 @default.
• W2157486406 cites W2103758231 @default.
• W2157486406 cites W2108883742 @default.
• W2157486406 cites W2114956710 @default.
• W2157486406 cites W2115077980 @default.
• W2157486406 cites W2123129045 @default.
• W2157486406 cites W2124312531 @default.
• W2157486406 cites W2124722077 @default.
• W2157486406 cites W2125955497 @default.
• W2157486406 cites W2127040105 @default.
• W2157486406 cites W2130809066 @default.
• W2157486406 cites W2146519887 @default.
• W2157486406 cites W2151396148 @default.
• W2157486406 cites W2158380191 @default.
• W2157486406 cites W2160028083 @default.
• W2157486406 cites W2163356394 @default.
• W2157486406 cites W2167027232 @default.
• W2157486406 cites W2326267820 @default.
• W2157486406 doi "https://doi.org/10.1007/s10549-009-0313-5" @default.
• W2157486406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19153828" @default.
• W2157486406 hasPublicationYear "2009" @default.
• W2157486406 type Work @default.
• W2157486406 sameAs 2157486406 @default.
• W2157486406 citedByCount "140" @default.
• W2157486406 countsByYear W21574864062012 @default.
• W2157486406 countsByYear W21574864062013 @default.
• W2157486406 countsByYear W21574864062014 @default.
• W2157486406 countsByYear W21574864062015 @default.
• W2157486406 countsByYear W21574864062016 @default.
• W2157486406 countsByYear W21574864062017 @default.
• W2157486406 countsByYear W21574864062018 @default.
• W2157486406 countsByYear W21574864062019 @default.
• W2157486406 countsByYear W21574864062020 @default.
• W2157486406 countsByYear W21574864062021 @default.
• W2157486406 countsByYear W21574864062022 @default.
• W2157486406 countsByYear W21574864062023 @default.
• W2157486406 crossrefType "journal-article" @default.
• W2157486406 hasAuthorship W2157486406A5047819372 @default.
• W2157486406 hasAuthorship W2157486406A5067182789 @default.
• W2157486406 hasAuthorship W2157486406A5075557023 @default.
• W2157486406 hasAuthorship W2157486406A5088845988 @default.
• W2157486406 hasBestOaLocation W21574864062 @default.
• W2157486406 hasConcept C121608353 @default.
• W2157486406 hasConcept C126322002 @default.
• W2157486406 hasConcept C126894567 @default.
• W2157486406 hasConcept C143998085 @default.
• W2157486406 hasConcept C168563851 @default.
• W2157486406 hasConcept C204243189 @default.
• W2157486406 hasConcept C2776067312 @default.
• W2157486406 hasConcept C2776694085 @default.
• W2157486406 hasConcept C2777176818 @default.
• W2157486406 hasConcept C2778043895 @default.
• W2157486406 hasConcept C29456083 @default.
• W2157486406 hasConcept C530470458 @default.
• W2157486406 hasConcept C71924100 @default.
• W2157486406 hasConceptScore W2157486406C121608353 @default.
• W2157486406 hasConceptScore W2157486406C126322002 @default.
• W2157486406 hasConceptScore W2157486406C126894567 @default.
• W2157486406 hasConceptScore W2157486406C143998085 @default.
• W2157486406 hasConceptScore W2157486406C168563851 @default.
• W2157486406 hasConceptScore W2157486406C204243189 @default.
• W2157486406 hasConceptScore W2157486406C2776067312 @default.
• W2157486406 hasConceptScore W2157486406C2776694085 @default.
• W2157486406 hasConceptScore W2157486406C2777176818 @default.
• W2157486406 hasConceptScore W2157486406C2778043895 @default.
• W2157486406 hasConceptScore W2157486406C29456083 @default.
• W2157486406 hasConceptScore W2157486406C530470458 @default.
• W2157486406 hasConceptScore W2157486406C71924100 @default.
• W2157486406 hasIssue "3" @default.
• W2157486406 hasLocation W21574864061 @default.
• W2157486406 hasLocation W21574864062 @default.

• next